Article Text

other Versions

PDF
Brachytherapy and endoresection for choroidal melanoma: a cohort study
  1. James C Rice1,
  2. Clare Stannard2,
  3. Colin Cook1,
  4. Karin Lecuona1,
  5. Landon Myer3,4,
  6. Raoul P Scholtz1
  1. 1Department of Ophthalmology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
  2. 2Department of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
  3. 3School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa
  4. 4Department of Epidemiology, Mailman School of Public Health, Columbia University, USA
  1. Correspondence to Dr James Rice, Department of Ophthalmology, Groote Schuur Hospital, Observatory, Cape Town 7925, South Africa; james.rice{at}uct.ac.za

Abstract

Aim To report and compare the outcomes of brachytherapy and endoresection in the conservative treatment of medium sized choroidal melanoma.

Methods A retrospective cohort study. Medium tumours were defined as 2.5–10 mm in height and less than 16 mm in the widest diameter. Consecutive patients undergoing brachytherapy at Groote Schuur Hospital were compared with a cohort undergoing endoresection from a national database.

Results 148 brachytherapy and 22 endoresection patients were followed for a median of 55.4 and 62.4 months, respectively. Tumours undergoing endoresection were thicker (7.3 vs 4.9 mm, p<0.001, Wilcoxon rank-sum test) and further from the fovea (5.2 vs 3.7 mm, p=0.05, Wilcoxon rank-sum test) than those treated with brachytherapy. Visual acuity of 6/18 or better was maintained in 41% of the endoresection group and 35% of the brachytherapy group. The likelihood of achieving a final visual acuity of better than 2/60 was 22% higher in the endoresection group (risk ratio 1.22, 95% CI 1.02 to 1.28, p=0.034). Rates of local recurrence (18.2% vs 14.9%, p=0.75) and metastases or death (18.2% vs 14.2%, p=0.75) were higher in the endoresection group, and the enucleation rate was lower in this group (4.6% vs 10.8%, p=0.70) but these were not statistically significant.

Conclusions The outcomes observed in this small cohort of endoresection patients suggest that endoresection of selected tumours may achieve better visual outcomes than brachytherapy. Rates of local recurrence, enucleation and metastases following endoresection require further research. Local recurrence is likely to be influenced by consolidation treatment methods.

  • Choroid
  • Treatment Surgery
  • Neoplasia
  • Vision

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.